176 related articles for article (PubMed ID: 7678396)
1. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.
Crane P; Laliberté R; Heminway S; Thoolen M; Orlandi C
Eur J Nucl Med; 1993 Jan; 20(1):20-5. PubMed ID: 7678396
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
Beller GA; Glover DK; Edwards NC; Ruiz M; Simanis JP; Watson DD
Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
[TBL] [Abstract][Full Text] [Related]
4. Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.
Weinstein H; Reinhardt CP; Wironen JF; Leppo JA
J Nucl Cardiol; 1994; 1(4):351-64. PubMed ID: 9420718
[TBL] [Abstract][Full Text] [Related]
5. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.
Liu Z; Johnson G; Beju D; Okada RD
J Nucl Cardiol; 2001; 8(6):677-86. PubMed ID: 11725264
[TBL] [Abstract][Full Text] [Related]
6. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-pyrophosphate uptake as an indicator of myocardial injury without infarct.
Okuda K; Nohara R; Fujita M; Tamaki N; Konishi J; Sasayama S
J Nucl Med; 1994 Aug; 35(8):1366-70. PubMed ID: 8046495
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of 99mTc-sestamibi evaluates the protective effects by ischaemic preconditioning on ischaemic myocardium in an isolated rabbit heart.
Liang J; Chen HL; Zhou Y; Xie M; Xu LM; Lin G
Nucl Med Commun; 2007 Nov; 28(11):864-9. PubMed ID: 17901770
[TBL] [Abstract][Full Text] [Related]
9. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
[TBL] [Abstract][Full Text] [Related]
10. Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
Kiser JW; Drane WE; Mastin ST; Nicole MW
Clin Nucl Med; 1998 Jul; 23(7):432-6. PubMed ID: 9676947
[TBL] [Abstract][Full Text] [Related]
11. (99m)Tc-sestamibi uptake in rat skeletal muscle and heart: physiological determinants and correlations.
Arsos G; Kyparos A; Moralidis E; Kyparos D; Georga S; Sotiriadou S; Matziari C; Karakatsanis C
Physiol Res; 2009; 58(1):21-28. PubMed ID: 18198988
[TBL] [Abstract][Full Text] [Related]
12. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis.
Sinusas AJ; Bergin JD; Edwards NC; Watson DD; Ruiz M; Makuch RW; Smith WH; Beller GA
Circulation; 1994 May; 89(5):2332-41. PubMed ID: 8181159
[TBL] [Abstract][Full Text] [Related]
13. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of technetium-99m-Sestamibi and thallium-201 in a transient ischemic myocardium animal model: insight into the 'redistribution' phenomenon.
Mousa SA; Cooney JM; Stevens S
Cardiology; 1992; 81(2-3):157-63. PubMed ID: 1286474
[TBL] [Abstract][Full Text] [Related]
15. Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
Liu Q; Zhao S; Yan C; Lu M; Jiang S; Zhang Y; Li S; Liu Y; Yang M; He Z
Nucl Med Commun; 2009 Aug; 30(8):610-6. PubMed ID: 19491715
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m sestamibi tomographic evaluation of residual ischemia after anterior myocardial infarction.
Marcassa C; Galli M; Temporelli PL; Campini R; Orrego PS; Zoccarato O; Giordano A; Giannuzzi P
J Am Coll Cardiol; 1995 Mar; 25(3):590-6. PubMed ID: 7860901
[TBL] [Abstract][Full Text] [Related]
17. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous silent myocardial ischemia assessed by technetium-99m-sestamibi imaging.
Samman B; Hahn SD; Messinger DE; Heller GV
J Nucl Med; 1993 Jan; 34(1):134-6. PubMed ID: 8418256
[TBL] [Abstract][Full Text] [Related]
19. Experimental studies of the physiologic properties of technetium-99m isonitriles.
Beller GA; Sinusas AJ
Am J Cardiol; 1990 Oct; 66(13):5E-8E. PubMed ID: 2145747
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
